Quick Answer
Semnur Pharmaceuticals, Inc. reported Diluted EPS of $0.78 per share (loss) for fiscal year 2025.
Semnur Pharmaceuticals, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.78 | -3800.0% |
| 2024 | -$0.02 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.76 | -7500.0% | -7500.0% |
| September 30, 2024 | -$0.01 | — | — |
- Semnur Pharmaceuticals, Inc. showed a decrease of -3800.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2024–2025 period, Semnur Pharmaceuticals, Inc.’s diluted eps has declined by 3800.0% (from $0.02 per share (loss) to $0.78 per share (loss)).
- The most recent figure is from Semnur Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: